Company · CIK 1347242
LIPELLA PHARMACEUTICALS INC.
| CIK | 1347242 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | PA |
| Listed | LIPO |
| First annual or quarterly report | 2023-03-31 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-276815 | 2024-02-01 | 2025-04-04 | 4 | |
| 333-286199 | 2025-03-28 | 2025-04-03 | 2 | |
| 333-284172 | 2025-01-07 | 2025-01-15 | 2 | |
| 333-275245 | 2023-11-01 | 2023-11-08 | 2 | |
| 333-266397 | 2022-07-29 | 2022-12-21 | 9 |
Filings
20| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-04-04 | 424B5Shelf takedown | 333-276815 | 0001753926-25-000582 |
| 2025-04-03 | EFFECTDeclared effective | 333-286199 | 9999999995-25-000977 |
| 2025-03-28 | S-3Shelf registered | 333-286199 | 0001753926-25-000509 |
| 2025-01-15 | EFFECTDeclared effective | 333-284172 | 9999999995-25-000124 |
| 2025-01-07 | S-3Shelf registered | 333-284172 | 0001753926-25-000059 |
| 2024-08-01 | 424B5Shelf takedown | 333-276815 | 0001753926-24-001320 |
| 2024-02-08 | EFFECTDeclared effective | 333-276815 | 9999999995-24-000363 |
| 2024-02-01 | S-3Shelf registered | 333-276815 | 0001753926-24-000198 |
| 2023-11-08 | EFFECTDeclared effective | 333-275245 | 9999999995-23-003255 |
| 2023-11-01 | S-1Registration filed | 333-275245 | 0001753926-23-001409 |
| 2022-12-21 | 424B4Final prospectus | 333-266397 | 0001753926-22-001640 |
| 2022-12-21 | 424B4Final prospectus | 333-266397 | 0001753926-22-001639 |
| 2022-12-19 | EFFECTDeclared effective | 333-266397 | 9999999995-22-003578 |
| 2022-12-15 | S-1/AAmendment | 333-266397 | 0001753926-22-001588 |
| 2022-12-13 | S-1/AAmendment | 333-266397 | 0001753926-22-001562 |
| 2022-12-08 | S-1/AAmendment | 333-266397 | 0001753926-22-001536 |
| 2022-11-28 | S-1/AAmendment | 333-266397 | 0001753926-22-001509 |
| 2022-10-24 | S-1/AAmendment | 333-266397 | 0001753926-22-001385 |
| 2022-07-29 | S-1Registration filed | 333-266397 | 0001753926-22-000986 |
| 2022-02-14 | DRSDraft made public | 377-06034 | 0001753926-22-000209 |